High Efficacy of Treatment with Sofosbuvir+GS-5816 ±Ribavirin for 12 Weeks in Treatment Experienced Patients with Genotype 1 or 3 HCV Infection

被引：0

作者：

Pianko, Stephen ^{[1
]}

Flamm, Steven L. ^{[2
]}

Shiffman, Mitchell L. ^{[3
]}

Kumar, Sonal ^{[4
]}

Strasser, Simone I. ^{[5
]}

Dore, Gregory J. ^{[6
]}

McNally, John ^{[7
]}

Brainard, Diana M. ^{[7
]}

Han, Lingling ^{[7
]}

Doehle, Brian ^{[7
]}

Mogalian, Erik ^{[7
]}

McHutchison, John G. ^{[7
]}

Reddy, K. Rajender ^{[8
]}

Roberts, Stuart K. ^{[9
]}

机构：

[1] Monash Med Ctr, Clayton, Vic 3168, Australia

[2] Northwestern Univ, Chicago, IL 60611 USA

[3] Liver Inst Virginia, Richmond, VA USA

[4] Weill Cornell Med Coll, New York, NY USA

[5] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia

[6] St Vincents Hosp, Darlinghurst, NSW 2010, Australia

[7] Gilead Sci Inc, Foster City, CA 94404 USA

[8] Univ Penn, Philadelphia, PA 19104 USA

[9] Alfred, Melbourne, Vic, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

197

引用

页码：297A / 298A

页数：2